心不全と骨格筋機能障害

出版社： 文光堂
著者：
発行日： 2018-07-18
分野： 医療技術  >  リハビリ技術
ISBN： 9784830645693
電子書籍版： 2018-07-18 （第1版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

5,280 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

5,280 円(税込)

購入する

商品紹介

超高齢社会を背景に心不全患者も増加している今日，診療報酬の改定も追い風となり，心不全の予防・治療そして予後改善のための運動療法が盛んに行われている．なぜ，心不全に運動なのか？心不全の理解を深めるための骨格筋障害の知識・考え方を解説．読者の理解を助ける多くのイラストと簡潔明瞭な解説により，これまで難解とされてきた心不全と運動器の関係がよく理解できる．心不全・慢性疾患の診療・リハビリテーションに従事する医療者が「心不全は心臓だけの病気ではない」ことを理解するための最良の一冊．

目次

  • 序　章
    　1 心不全における骨格筋障害に関する研究の発展
    　2 慢性心不全と運動耐容能に関する盲点と要点

    第I章　心不全における骨格筋障害
    　1 運動耐容能規定因子：limiting factors for exercise capacity
    　2 骨格筋はどのように酸素摂取量に影響するのか？
    　3 心不全における運動耐容能規定因子
    　4 運動限界における酸素輸送限界説と骨格筋利用限界説：微小循環の問題
    　　　─debates continue─
    　5 心不全における骨格筋障害
    　6 骨格筋障害の成因
    　7 骨格筋障害への対策
    　8 HFpEFにおける運動耐容能低下と骨格筋障害

    第II章　骨格筋という高次機能臓器（master regulator for health）
    　　　　　─運動器でありながら内分泌機能を有する巨大な臓器─
    　1 運動疫学から骨格筋疫学へ
    　2 健康を支える内分泌臓器としての骨格筋
    　3 サルコペニア，フレイル，ロコモティブ・シンドローム

    第III章　運動を支える循環系のしくみ─心臓から毛細血管まで─
    循環生理の要点
    　1 心臓・循環系
    　2 心臓への静脈還流
    　3 動脈・静脈の構造
    　4 血管平滑筋
    　5 末梢循環系
    　6 循環調節
    　7 運動中の循環調節
    　8 慢性心不全の要点

    第IV章　運動療法の実際
    　1 心疾患における運動トレーニング様式—運動強度・運動時間・運動様式—
    　2 心疾患に対する運動療法・リハビリテーションの実際
    　3 心臓リハ・運動療法の実際（民間病院での実地例）
    　4 高齢者向け運動プログラム
    　5 多様な運動療法・運動療法実地の工夫

    第V章　心肺運動負荷試験・運動機能評価法・運動効果モニタリング
    　1 心肺運動負荷試験の要点
    　2 リハビリテーション現場におけるさまざまな指標
    　3 運動療法・心臓リハビリテーションの効果と科学的モニタリング

    第VI章　栄養管理・食事療法─カヘキシーへの対策と課題─
    　1 心不全における栄養障害と悪液質
    　2 栄養評価
    　3 心不全における栄養不良例への介入方法
    　4 肥満パラドクス
    　5 肥満を改善する食事療法について

    トピックス
    　トピックス 1　骨格筋機能改善薬
    　トピックス 2　生物とホルミシス（hormesis）
    　トピックス 3　内分泌器官としての骨

    終　章
    ヒトにおける運動療法・心臓リハビリテーションの意義
    　1 ヒトという生命体
    　2 運動は全身の器官および細胞・組織を1 つの目的に向かって活動させる
    　3 おわりに─“Beyond exercise and cardiac rehabilitation”

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

第I章 心不全における骨格筋障害

P.10 掲載の参考文献
1) Wasserman K et al : Principles of Exercise Testing and Interpretation, Lippincott Williams & Wilkins, 2011
 
2) Sullivan MJ et al : Exercise intolerance in patients with chronic heart failure. Prog Cardiovasc Dis 38 (1):1-22, 1995
PubMed
3) Rubin SA et al : Arterial oxygenation and arterial oxygen transport in chronic myocardial failure at rest, during exercise and after hydralazine treatment. Circulation 66 (1):143-148, 1982
PubMed
4) Santos M et al : Central cardiac limit to aerobic capacity in patients with exertional pulmonary venous hypertension : implications for heart failure with preserved ejection fraction. Circ Heart Fail 8 (2):278-285, 2015
PubMed
5) Okita K et al : Exercise intolerance in chronic heart failure-skeletal muscle dysfunction and potential therapies. Circ J 77 (2):293-300, 2013
PubMed
6) Kayser B : Exercise starts and ends in the brain. Eur J Appl Physiol 90 (Issue 3-4):411-419, 2003
 
7) Richardson RS et al : Increased V4O2 max with rightshifted Hb-O2 dissociation curve at a constant O2 delivery in dog muscle in situ. J Appl Physiol 84 (3):995-1002, 1998
 
8) von Haehling S et al : Anemia in chronic heart failure : can we treat? What to treat? Heart Fail Rev 17 (2):203-210, 2012
PubMed
9) Swedberg K et al : Treatment of anemia with darbepoetin alfa in systolic heart failure. N Engl J Med 368 (13):1210-1219, 2013
PubMed
10) Anand IS : Pathophysiology of anemia in heart failure. Heart Fail Clin 6 (3):279-288, 2010
PubMed
11) Brooks GA et al : Exercise Physiology:Human Bioenergetics and Its Applications, 4th ed, McGraw-Hill Publishing Company, 2005
 
12) McArdle WD et al : Exercise Physiology:Nutrition, Energy, and Human Performance Seventh, International Edition Edition. Lippincott Williams & Wilkins, 2014
 
P.13 掲載の参考文献
1) Taivassalo T et al : Venous oxygen levels during aerobic forearm exercise:An index of impaired oxidative metabolism in mitochondrial myopathy. Ann Neurol 51 (1):38-44, 2002
PubMed
2) Dhakal BP et al : Mechanisms of exercise intolerance in heart failure with preserved ejection fraction:the role of abnormal peripheral oxygen extraction. Circ Heart Fail 8 (2):286-294, 2015
PubMed
3) Okita K et al : Skeletal muscle metabolism in maximal bicycle and treadmill exercise distinguished by using in-vivo metabolic freeze method and phosphorus-31 magnetic resonance spectroscopy in normal men. Am J Cardiol 81:106-109, 1998
PubMed
P.16 掲載の参考文献
1) Brooks GA et al : Exercise Physiology : Human Bioenergetics and Its Applications, 4th ed, McGraw-Hill, 2004
 
2) Hirai DM et al : Exercise training in chronic heart failure : improving skeletal muscle O2 transport and utilization. Am J Physiol Heart Circ Physiol 309 (9):H1419-1439, 2015
PubMed
3) Wasserman K et al : Principles of Exercise Testing and Interpretation, Lippincott Williams and Wilkins, 2011
 
4) Radak Z et al : Adaptation to exercise-induced oxidative stress : from muscle to brain. Exerc Immunol Rev 7:90-107, 2001
PubMed
P.27 掲載の参考文献
1) Maskin CS et al : Failure of dobutamine to increase exercise capacity despite hemodynamic improvement in severe chronic heart failure. Am J Cardiol 51 (1):177-182, 1983
PubMed
2) Wilson JR et al : Impaired skeletal muscle nutritive flow during exercise in patients with congestive heart failure : role of cardiac pump dysfunction as determined by the effect of dobutamine. Am J Cardiol 53 (9):1308-1315, 1984
PubMed
3) Carell ES et al : Maximal exercise tolerance in chronic congestive heart failure. Relationship to resting left ventricular function. Chest 106 (6):1746-1752, 1994
PubMed
4) Okita K et al : Exercise intolerance in chronic heart failure-skeletal muscle dysfunction and potential therapies. Circ J 77 (2):293-300, 2013
PubMed
5) Hill AV et al : Muscular exercise, lactic acid, and the supply and utilisation of oxygen. -Parts IV-VI. Proc Roy Soc Lond B 96:438-447, 1924
 
6) Muller AF et al : Regional blood flow in chronic heart failure : the reason for the lack of correlation between patients' exercise tolerance and cardiac output? Br Heart J 67 (6):478-481, 1992
PubMed
7) Jondeau G et al : Active skeletal muscle mass and cardiopulmonary reserve. Failure to attain peak aerobic capacity during maximal bicycle exercise in patients with severe congestive heart failure. Circulation 86 (5):1351-1356, 1992
PubMed
8) Wiener DH et al : Abnormal skeletal muscle bioenergetics during exercise in patients with heart failure : role of reduced muscle blood flow. Circulation 73 (6):1127-1136, 1986
PubMed
9) Clark AL et al : Exercise limitation in chronic heart failure : central role of the periphery. J Am Coll Cardiol 28 (5):1092-1102, 1996
PubMed
10) Okita K et al : Skeletal Muscle Metabolism Limits Exercise Capacity in Patients With Chronic Heart Failure. Circulation 98:1886-1891, 1998
PubMed
11) Middlekauff HR : Making the case for skeletal myopathy as the major limitation of exercise capacity in heart failure. Circ Heart Fail 3 (4):537-546, 2010
PubMed
12) Yasu T et al : Delayed improvement in skeletal muscle metabolism and exercise capacity in patients with mitral stenosis following immediate hemodynamic amelioration by percutaneous transvenous mitral commissurotomy. Am J Cardiol 77 (7):492-497, 1996
PubMed
13) Russell SD et al : Lack of effect of increased inspired oxygen concentrations on maximal exercise capacity or ventilation in stable heart failure. Am J Cardiol 84 (12):1412-1416, 1999
PubMed
P.35 掲載の参考文献
1) Rubin SA et al : Arterial oxygenation and arterial oxygen transport in chronic myocardial failure at rest, during exercise and after hydralazine treatment. Circulation 66 (1):143-148, 1982
PubMed
2) Okita K et al : Exercise intolerance in chronic heart failure--skeletal muscle dysfunction and potential therapies. Circ J 77 (2):293-300, 2013
PubMed
3) Dhakal BP et al : Mechanisms of exercise intolerance in heart failure with preserved ejection fraction : the role of abnormal peripheral oxygen extraction. Circ Heart Fail 8 (2):286-294, 2015
PubMed
4) Maskin CS et al : Failure of dobutamine to increase exercise capacity despite hemodynamic improvement in severe chronic heart failure. Am J Cardiol 51 (1):177-182, 1983
PubMed
5) Wilson J R et al : Impaired skeletal muscle nutritive flow during exercise in patients with congestive heart failure : role of cardiac pump dysfunction as determined by the effect of dobutamine. Am J Cardiol 53 (9):1308-1315, 1984
PubMed
6) Wiener DH et al : Abnormal skeletal muscle bioenergetics during exercise in patients with heart failure : role of reduced muscle blood flow. Circulation 73 (6):1127-1136, 1986
PubMed
7) Poole DC et al : Muscle oxygen transport and utilization in heart failure : implications for exercise (in) tolerance. Am J Physiol Heart Circ Physiol 302 (5):H1050-1063, 2012
PubMed
8) Hirai DM et al : Exercise training in chronic heart failure : improving skeletal muscle O2 transport and utilization. Am J Physiol Heart Circ Physiol 309 (9):H1419-1439, 2015
PubMed
9) Russell SD et al : Lack of effect of increased inspired oxygen concentrations on maximal exercise capacity or ventilation in stable heart failure. Am J Cardiol 84 (12):1412-1416, 1999
PubMed
10) Esposito F et al : Limited maximal exercise capacity in patients with chronic heart failure:partitioning the contributors. J Am Coll Cardiol 55 (18):1945-1954, 2010
PubMed
11) Yasu T et al : Delayed improvement in skeletal muscle metabolism and exercise capacity in patients with mitral stenosis following immediate hemodynamic amelioration by percutaneous transvenous mitral commissurotomy. Am J Cardiol 77 (7):492-497, 1996
PubMed
12) Hanada A et al : Dissociation between muscle metabolism and oxygen kinetics during recovery from exercise in patients with chronic heart failure. Heart 83 (2):161-166, 2000
PubMed
13) Wittenberg BA et al : Transport of oxygen in muscle. Annu Rev Physiol 51:857-878, 1989
PubMed
14) Richardson RS et al : Myoglobin O2 desaturation during exercise. Evidence of limited O2 transport. J Clin Invest 96 (4):1916-1926, 1995
PubMed
15) Tabet JY et al : Absence of exercise capacity improvement after exercise training program : a strong prognostic factor in patients with chronic heart failure. Circ Heart Fail 1 (4):220-226, 2008
 
P.39 掲載の参考文献
1) Wiener DH et al : Abnormal skeletal muscle bioenergetics during exercise in patients with heart failure : role of reduced muscle blood flow. Circulation 73 (6):1127-1136, 1986
PubMed
2) Sullivan MJ et al : Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure. Circulation 81 (2):518-527, 1990
PubMed
3) Clark AL et al : Exercise limitation in chronic heart failure : central role of the periphery. J Am Coll Cardiol 28 (5):1092-1102, 1996
PubMed
4) Middlekauff HR : Making the case for skeletal myopathy as the major limitation of exercise capacity in heart failure. Circ Heart Fail 3 (4):537-546, 2010
PubMed
5) Okita K et al : Skeletal muscle metabolism limits exercise capacity in patients with chronic heart failure. Circulation 98:1886-1891, 1998
PubMed
6) Okita K et al : Skeletal muscle metabolism in maximal bicycle and treadmill exercise distinguished by using in vivo metabolic freeze method and phosphorus-31 magnetic resonance spectroscopy in normal men. Am J Cardiol 81 (1):106-109, 1998
PubMed
7) Franssen FM et al : The contribution of starvation, deconditioning and ageing to the observed alterations in peripheral skeletal muscle in chronic organ diseases. Clin Nutr 21 (1):1-14, 2002
 
8) Duscha BD et al : Implications of chronic heart failure on peripheral vasculature and skeletal muscle before and after exercise training. Heart Fail Rev 13 (1):21-37, 2008
PubMed
9) Strassburg S et al : Muscle wasting in cardiac cachexia. Int J Biochem Cell Biol 37 (10):1938-1947, 2005
PubMed
10) Dalla Libera L et al : Physiological basis for contractile dysfunction in heart failure. Curr Pharm Des 14 (25):2572-2581, 2008
PubMed
11) Okita K : Skeletal muscle metabolism during exercise in chronic heart failure. Cardiopulmonary Exercise Testing and Cardiovascular Health, Wasserman K ed, Futura Publishing Company, p27-39, 2002
 
P.47 掲載の参考文献
1) Clark AL et al : Exercise limitation in chronic heart failure : central role of the periphery. J Am Coll Cardiol 28 (5):1092-1102, 1996
PubMed
2) Middlekauff HR : Making the case for skeletal myopathy as the major limitation of exercise capacity in heart failure. Circ Heart Fail 3 (4):537-546, 2010
PubMed
3) Franssen FM et al : The contribution of starvation, deconditioning and ageing to the observed alterations in peripheral skeletal muscle in chronic organ diseases. Clin Nutr 21 (1):1-14, 2002
 
4) Okita K et al : Exercise intolerance in chronic heart failure. Circ J 77 (2):293-300, 2013
PubMed
5) Kinugawa S et al : Skeletal Muscle Abnormalities in Heart Failure. Int Heart J 56 (5):475-484, 2015
PubMed
6) Kemp GJ et al : Abnormalities in exercising skeletal muscle in congestive heart failure can be explained in terms of decreased mitochondrial ATP synthesis, reduced metabolic efficiency, and increased glycogenolysis. Heart 76 (1):35-41, 1996
PubMed
7) Duscha BD et al : Implications of chronic heart failure on peripheral vasculature and skeletal muscle before and after exercise training. Heart Fail Rev 13 (1):21-37, 2008
PubMed
8) Okita K : Skeletal muscle metabolism during exercise in chronic heart failure. Cardiopulmonary Exercise Testing and Cardiovascular Health. Wasserman K (ed), Armork, NY : Futura Publishing Company, Inc ; p27-39, 2002
 
9) Saitoh M et al : Muscle wasting in heart failure : The role of nutrition. Wien Klin Wochenschr 128(Suppl 7):455-465, 2016
 
10) Man WD et al : Skeletal muscle dysfunction in COPD : clinical and laboratory observations. Clin Sci (Lond) 117 (7):251-264, 2009
PubMed
11) Rubin SA et al : Arterial oxygenation and arterial oxygen transport in chronic myocardial failure at rest, during exercise and after hydralazine treatment. Circulation 66 (1):143-148, 1982
PubMed
12) Ostrander EA et al : Genetics of athletic performance. Annu Rev Genomics Hum Genet 10:407-429, 2009
PubMed
13) Dalla Libera L et al : Physiological basis for contractile dysfunction in heart failure. Curr Pharm Des 14 (25):2572-2581, 2008
PubMed
14) Ventura-Clapier R et al : Metabolic myopathy in heart failure. News Physiol Sci 17:191-196, 2002
PubMed
15) Anker SD et al : Acquired growth hormone resistance in patients with chronic heart failure:implications for therapy with growth hormone. J Am Coll Cardiol 38 (2):443-452, 2001
PubMed
16) Schulze PC et al : Insulin-like growth factor-1 and muscle wasting in chronic heart failure. Int J Biochem Cell Biol 37 (10):2023-2035, 2005
PubMed
17) Osterziel KJ et al : Randomised, double-blind, placebocontrolled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy. Lancet 351 (9111):1233-1237, 1998
PubMed
18) Cittadini A et al : Growth hormone deficiency in patients with chronic heart failure and beneficial effects of its correction. J Clin Endocrinol Metab 94 (9):3329-3336, 2009
PubMed
19) Jankowska EA et al : Anabolic deficiency in men with chronic heart failure : prevalence and detrimental impact on survival. Circulation 114 (17):1829-1837, 2006
PubMed
20) Bendayan M et al : Therapeutic interventions for frail elderly patients : Part II. ongoing and unpublished randomized trials. Prog Cardiovasc Dis 57 (2):144-151, 2014
PubMed
21) Bhattacharya I et al : Safety, pharmacokinetic, and pharmacodynamic evaluation after single and multiple ascending doses of a novel selective androgen receptor modulator in healthy subjects. Clin Ther 38 (6):1401-1416, 2016
PubMed
22) Strassburg S et al : Muscle wasting in cardiac cachexia. Int J Biochem Cell Biol 37 (10):1938-1947, 2005
PubMed
23) Ebner N et al : Mechanism and novel therapeutic approaches to wasting in chronic disease. Maturitas 75 (3):199-206, 2013
PubMed
24) Kinugawa S et al : Treatment with dimethylthiourea prevents left ventricular remodeling and failure after experimental myocardial infarction in mice:role of oxidative stress. Circ Res 87 (5):392-398, 2000
PubMed
25) Tsutsui H et al : Enhanced generation of reactive oxygen species in the limb skeletal muscles from a murine infarct model of heart failure. Circulation 104 (2):134-136, 2001
PubMed
26) Hirabayashi K et al : Intramyocellular lipid is increased in the skeletal muscle of patients with dilated cardiomyopathy with lowered exercise capacity. Int J Cardiol 176 (3):1110-1112, 2014
PubMed
P.51 掲載の参考文献
1) Okita K et al : Exercise intolerance in chronic heart failure--skeletal muscle dysfunction and potential therapies. Circ J 77 (2):293-300, 2013
PubMed
2) Ebner N et al : Mechanism and novel therapeutic approaches to wasting in chronic disease. Maturitas 75 (3):199-206, 2013
PubMed
3) Conraads VM et al : Unraveling new mechanisms of exercise intolerance in chronic heart failure : role of exercise training. Heart Fail Rev 18 (1):65-77, 2013
PubMed
4) Granata C et al : Training intensity modulates changes in PGC-1α and p53 protein content and mitochondrial respiration, but not markers of mitochondrial content in human skeletal muscle. FASEB J 30 (2):959-970, 2016
 
5) Bishop DJ et al : Can we optimise the exercise training prescription to maximise improvements in mitochondria function and content? Biochim Biophys Acta 1840 (4):1266-1275, 2014
PubMed
6) Schoenfeld BJ : Is there a minimum intensity threshold for resistance training-induced hypertrophic adaptations? Sports Med 43 (12):1279-1288, 2013
 
7) Takada S et al : Low-intensity exercise can increase muscle mass and strength proportionally to enhanced metabolic stress under ischemic conditions. J Appl Physiol (1985) 113 (2):199-205, 2012
PubMed
8) Takahashi M et al : Low-intensity exercise under ischemic conditions enhances metabolic stress in patients with heart failure. Int J Cardiol 201:142-144, 2015
PubMed
9) Patwala AY et al : Maximizing patient benefit from cardiac resynchronization therapy with the addition of structured exercise training : a randomized controlled study. J Am Coll Cardiol 53 (25):2332-2339, 2009
PubMed
10) Rogers JG et al : Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients. J Am Coll Cardiol 55 (17):1826-1834, 2010
PubMed
11) Kadoguchi T et al : Angiotensin II can directly induce mitochondrial dysfunction, decrease oxidative fibre number and induce atrophy in mouse hindlimb skeletal muscle. Exp Physiol 100 (3):312-322, 2015
PubMed
12) Yoshida T et al : Molecular mechanisms and signaling pathways of angiotensin II-induced muscle wasting : potential therapeutic targets for caediac cachexia. Int J Biochem Cell Biol 45 (10):2322-2332, 2013
 
13) Takada S et al : Angiotensin II receptor blocker improves the lowered exercise capacity and impaired mitochondrial function of the skeletal muscle in type 2 diabetic mice. J Appl Physiol (1985) 114 (7):844-857, 2013
PubMed
14) Fukushima A et al : Direct renin inhibitor ameliorates insulin resistance by improving insulin signaling and oxidative stress in the skeletal muscle from postinfarct heart failure in mice. Eur J Pharmacol 779:147-156, 2016
PubMed
15) Jones A et al : Skeletal muscle RAS and exercise performance. Int J Biochem Cell Biol 35 (6):855-866, 2003
PubMed
16) Zhou LS et al : Effect of Angiotensin-Converting Enzyme Inhibitors on Physical Function in Elderly Subjects : A Systematic Review and Meta-Analysis. Drugs Aging 32 (9):727-735, 2015
PubMed
17) Toma M et al : Testosterone supplementation in heart failure : a meta-analysis. Circ Heart Fail 5 (3):315-321, 2012
PubMed
18) Cittadini A et al : Growth hormone deficiency in patients with chronic heart failure and beneficial effects of its correction. J Clin Endocrinol Metab 94 (9):3329-3336, 2009
PubMed
19) Bendayan M et al : Therapeutic interventions for frail elderly patients : part II. Ongoing and unpublished randomized trials. Prog Cardiovasc Dis 57 (2):144-151, 2014
PubMed
20) Bhattacharya I et al : Safety, Pharmacokinetic, and Pharmacodynamic Evaluation After Single and Multiple Ascending Doses of a Novel Selective Androgen Receptor Modulator in Healthy Subjects. Clin Ther 38 (6):1401-1416, 2016
PubMed
21) Dschietzig TB : Myostatin-From the Mighty Mouse to cardiovascular disease and cachexia. Clin Chhim Acta 433:216-224, 2014
 
22) Schuelke M et al : Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med 350:2682-2688, 2004
 
23) Camporez JP et al : Anti-myostatin antibody increases muscle mass and strength and improves insulin sensitivity in old mice. Proc Natl Acad Sci U.S.A. 113 (8):2212-2217, 2016
PubMed
24) Cohen S et al : Muscle wasting in disease : molecular mechanisms and promising therapies. Nat Rev Drug Discov 14:58-74, 2015
PubMed
25) Loncar G et al : Cardiac cachexia : hic et nunc : "hic et nunc" -here and now. Int J Cardiol 201:e1-12, 2015
PubMed
26) Dutt V et al : Skeletal muscle atrophy : Potential therapeutic agents and their mechanisms of action. Pharmacol Res 99:86-100, 2015
PubMed
P.55 掲載の参考文献
1) Borlaug BA : The pathophysiology of heart failure with preserved ejection fraction. Nat Rev Cardiol 11 (9):507-515, 2014
PubMed
2) Kitzman DW et al : Skeletal muscle abnormalities and exercise intolerance in older patients with heart failure and preserved ejection fraction. Am J Physiol Heart Circ Physiol 306 (9):H1364-1370, 2014
PubMed
3) Dhakal BP et al : Mechanisms of exercise intolerance in heart failure with preserved ejection fraction : the role of abnormal peripheral oxygen extraction. Circ Heart Fail 8 (2):286-294, 2015
PubMed
4) Sarma S et al : Soothing the sleeping giant : improving skeletal muscle oxygen kinetics and exercise intolerance in HFpEF. J Appl Physiol (1985) 119 (6):734-738, 2015
PubMed
5) Upadhya B et al : Exercise intolerance in heart failure with preserved ejection fraction : more than a heart problem. J Geriatr Cardiol 12 (3):294-304, 2015
PubMed
6) Kitzman DW et al : Exercise training in older patients with heart failure and preserved ejection fraction : a randomized, controlled, single-blind trial. Circ Heart Fail 3 (6):659-667, 2010
PubMed
7) Haykowsky MJ et al : Effect of endurance training on the determinants of peak exercise oxygen consumption in elderly patients with stable compensated heart failure and preserved ejection fraction. J Am Coll Cardiol 60 (2):120-128, 2012
PubMed
8) Pandey A et al : Exercise training in patients with heart failure and preserved ejection fraction : metaanalysis of randomized control trials. Circ Heart Fail 8 (1):33-40, 2015
PubMed
9) Santos M et al : Central cardiac limit to aerobic capacity in patients with exertional pulmonary venous hypertension : implications for heart failure with preserved ejection fraction. Circ Heart Fail 8 (2):278-285, 2015
PubMed
P.63 掲載の参考文献
1) Wallimann T et al : The creatine kinase system and pleiotropic effects of creatine. Amino Acids 40 (5):1271-1296, 2011
PubMed
2) Ydfors M et al : Modelling in vivo creatine/phosphocreatine in vitro reveals divergent adaptations in human muscle mitochondrial respiratory control by ADP after acute and chronic exercise. J Physiol 594 (11):3127-3140, 2016
PubMed
3) Nasrallah F et al : Creatine and creatine deficiency syndromes : biochemical and clinical aspects. Pediatr Neurol 42 (3):163-171, 2010
PubMed
4) Wyss M et al : Creatine and creatinine metabolism. Physiol Rev 80 (3):1107-1213, 2000
PubMed
5) Schulze A : Creatine deficiency syndromes. Mol Cell Biochem 244 (1-2):143-150, 2003
 

第II章 骨格筋という高次機能臓器 ( master regulator for health ) - 運動器でありながら内分泌機能を有する巨大な臓器 -

P.73 掲載の参考文献
1) Kiraly MA et al : The effect of exercise on hippocampal integrity : review of recent research. Int J Psychiatry Med 35 (1):75-89, 2005
PubMed
2) Booth FW et al : Exercise controls gene expression. American Scientists 93 (1):28-35, 2005
 
3) Paffenbarger RS Jr et al : Physical activity as an index of heart attack risk in college alumni. Am J Epidemiol 108 (3):161-175, 1978
PubMed
4) Paffenbarger RS Jr et al : Physical activity, all-cause mortality, and longevity of college alumni. N Engl J Med 314 (10):605-613, 1986
PubMed
5) Wannamethee SG et al : Changes in physical activity, mortality, and incidence of coronary heart disease in older men. Lancet 351 (9116):1603-1608, 1998
PubMed
6) Wannamethee SG et al : Physical activity and mortality in older men with diagnosed coronary heart disease. Circulation 102 (12):1358-1363, 2000
PubMed
7) Myers J et al : Exercise capacity and mortality among men referred for exercise testing.N Engl J Med 346 (11):793-801, 2002
PubMed
8) Wei M et al : Low cardiorespiratory fitness and physical inactivity as predictors of mortality in men with type 2 diabetes. Ann Intern Med 132 (8):605-611, 2000
PubMed
9) Sietsema KE et al : Exercise capacity as a predictor of survival among ambulatory patients with end-stage renal disease. Kidney Int 65 (2):719-724, 2004
PubMed
10) Waschki B et al : Physical activity is the strongest predictor of all-cause mortality in patients with COPD : a prospective cohort study. Chest 140 (2):331-342, 2011
PubMed
11) Mancini DM et al : Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 83 (3):778-786, 1991
PubMed
12) Gielen S et al : Exercise training in patients with heart disease : review of beneficial effects and clinical recommendations. Prog Cardiovasc Dis 57 (4):347-355, 2015
PubMed
13) Corra U et al : Cardiopulmonary exercise testing in systolic heart failure in 2014 : the evolving prognostic role:a position paper from the committee on exercise physiology and training of the heart failure association of the ESC. Eur J Heart Fail 16 (9):929-941, 2014
 
14) Pajonk FG et al : Hippocampal plasticity in response to exercise in schizophrenia. Arch Gen Psychiatry 67 (2):133-143, 2010
PubMed
15) White LJ et al : Exercise and brain health--implications for multiple sclerosis : Part 1--neuronal growth factors. Sports Med 38 (2):91-100, 2008
 
16) White LJ et al : Exercise and brain health--implications for multiple sclerosis : Part II--immune factors and stress hormones. Sports Med 38 (3):179-186, 2008
 
17) Newman AB et al : Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort. J Gerontol A Biol Sci Med Sci 61 (1):72-77, 2006
 
18) Hulsmann M et al : Muscle strength as a predictor of long-term survival in severe congestive heart failure. Eur J Heart Fail 6 (1):101-107, 2004
PubMed
19) Leong DP et al : Prognostic value of grip strength : findings from the Prospective Urban Rural Epidemiology (PURE) study. Lancet 386 (9990):266-273, 2015
PubMed
20) Heitmann BL et al : Thigh circumference and risk of heart disease and premature death : prospective cohort study. BMJ 339:b3292, doi:10.1136/bmj. b3292, 2009
 
21) Cutler RG : Evolutionary biology of aging and longevity in mammalian species. Aging and cell function, Johnson, JE (ed), Plenum Press, 1-147, 1984
 
22) Cutler RG : Oxidative stress profiling : part I. Its potential importance in the optimization of human health. Ann N Y Acad Sci 1055:93-135, 2005
PubMed
23) Cutler RG : Human longevity and aging : possible role of reactive oxygen species. Ann N Y Acad Sci 621:1-28, 1991
PubMed
24) Isoyama N et al : Comparative associations of muscle mass and muscle strength with mortality in dialysis patients. Clin J Am Soc Nephrol 9 (10):1720-1728, 2014
PubMed
25) Roshanravan B et al : Association between physical performance and all-cause mortality in CKD. J Am Soc Nephrol 24 (5):822-830, 2013
PubMed
26) 堀田饒ほか:アンケート調査による日本人糖尿病の死因-1991～2000年の10年間, 18,385名での検討-. 糖尿病 50 (1):47-61, 2007
 
27) Hasin T et al : Patients with heart failure have an increased risk of incident cancer. J Am Coll Cardiol 62 (10):881-886, 2013
 
P.79 掲載の参考文献
1) Steensberg A et al : Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6. J Physiol 529 (Pt 1):237-242, 2000
 
2) Pedersen BK et al : Role of myokines in exercise and metabolism. J Appl Physiol 103 (3):1093-1098, 2007
PubMed
3) Pedersen BK et al : Role of exercise-induced brainderived neurotrophic factor production in the regulation of energy homeostasis in mammals. Exp Physiol 94 (12):1153-1160, 2009
PubMed
4) Pedersen BK et al : Muscles, exercise and obesity : skeletal muscle as a secretory organ. Nat Rev Endocrinol 8 (8):457-465, 2012
PubMed
5) Demontis F et al : The influence of skeletal muscle on systemic aging and lifespan. Aging Cell 12 (6):943-949, 2013
PubMed
6) Scheele C et al : ROS and myokines promote muscle adaptation to exercise. Trends Endocrinol Metab 20 (3):95-99, 2009
PubMed
7) Cutler RG:Oxidative stress profiling : part I. Its potential importance in the optimization of human health. Ann N Y Acad Sci 1055:93-135, 2005
PubMed
8) Pajonk FG et al : Hippocampal plasticity in response to exercise in schizophrenia. Arch Gen Psychiatry 67 (2):133-143, 2010
PubMed
9) White LJ et al : Exercise and brain health--implications for multiple sclerosis : Part 1--neuronal growth factors. Sports Med 38 (2):91-100, 2008
 
10) White LJ et al : Exercise and brain health--implications for multiple sclerosis : Part II--immune factors and stress hormones. Sports Med 38 (3):179-186, 2008
 
11) Leal G et al : Regulation of hippocampal synaptic plasticity by BDNF. Brain Res pii:S0006-8993 (14) 01421-8, 2014
 
12) Laske C et al : Stage-dependent BDNF serum concentrations in Alzheimer's disease. J Neural Transm 113 (9):1217-1224, 2006
PubMed
13) Karege F et al : Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res 109 (2):143-148, 2002
PubMed
14) Connor B et al : Brain-derived neurotrophic factor is reduced in Alzheimer's disease. Brain Res Mol Brain Res. 49 (1-2):71-81, 1997
 
15) Rothman SM et al : Brain-derived neurotrophic factor as a regulator of systemic and brain energy metabolism and cardiovascular health. Ann N Y Acad Sci 1264:49-63, 2012
PubMed
16) Marosi K et al : BDNF mediates adaptive brain and body responses to energetic challenges. Trends Endocrinol Metab 25 (2):89-98, 2014
PubMed
17) Fukushima A et al : Decreased serum brain-derived neurotrophic factor levels are correlated with exercise intolerance in patients with heart failure. Int J Cardiol 168 (5):e142-144, 2013
PubMed
P.88 掲載の参考文献
1) Chen LK et al : Sarcopenia in Asia : consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 15 (2):95-101, 2014
 
2) Martin L et al : Cancer cachexia in the age of obesity : skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol 31 (12):1539-1547, 2013
PubMed
3) Xue QL et al : Initial manifestations of frailty criteria and the development of frailty phenotype in the Women's Health and Aging Study II. J Gerontol A Biol Sci Med Sci 63 (9):984-990, 2008
 
4) Weiss CO : Frailty and chronic diseases in older adults. Clin Geriatr Med 27 (1):39-52, 2011
PubMed
5) Walston J et al : Research agenda for frailty in older adults : toward a better understanding of physiology and etiology : summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults. J Am Geriatr Soc 54 (6):991-1001, 2006
 
6) Morley JE et al : Frailty consensus : a call to action. J Am Med Dir Assoc 14 (6):392-397, 2013
 
7) Singh M et al : Importance of frailty in patients with cardiovascular disease. Eur Heart J 35 (26):1726-1731, 2014
PubMed
8) Peterson MJ et al : Physical activity as a preventative factor for frailty : the health, aging, and body composition study. J Gerontol A Biol Sci Med Sci 64 (1):61-68, 2009
PubMed
9) Bendayan M et al : Therapeutic interventions for frail elderly patients : part II. Ongoing and unpublished randomized trials. Prog Cardiovasc Dis 57 (2):144-151, 2014
PubMed
10) Cadore EL et al : Strength and endurance training prescription in healthy and frail elderly. Aging Dis 5 (3):183-195, 2014
PubMed
11) Lam FM et al : The effect of whole body vibration on balance, mobility and falls in older adults : a systematic review and meta-analysis. Maturitas 72 (3):206-213, 2012
PubMed
12) Piepoli MF et al : Exercise training in heart failure : from theory to practice. A consensus document of the Heart Failure Association and the European Association for Cardiovascular Prevention and Rehabilitation. Eur J Heart Fail 13 (4):347-357, 2011
 

第III章 運動を支える循環系のしくみ - 心臓から毛細血管まで -

P.100 掲載の参考文献
1) Smith JJ : Circulatory Physiology : The Essentials, Williams & Wilkins, 1990
 
2) Rowell LB : Human Cardiovascular Control, Oxford University Press, 1993
 
3) Brooks GA et al : Exercise Physiology : Human Bioenergetics and Its Applications, 3rd ed, 2000
 
4) Green DJ et al : Soleus Muscle as a Surrogate for Health Status in Human Heart Failure. Exerc Sport Sci Rev 44 (1):45-50, 2016
PubMed
5) Panizzolo FA et al : Is the soleus a sentinel muscle for impaired aerobic capacity in heart failure? Med Sci Sports Exerc 47 (3):498-508, 2015
PubMed
6) Okita K et al : Muscle high-energy metabolites and metabolic capacity in patients with heart failure. Med Sci Sports Exerc 33 (3):442-448, 2001
PubMed
7) Nagai T et al : Comparisons of the skeletal muscle metabolic abnormalities in the arm and leg muscles of patients with chronic heart failure. Circ J 68 (6):573-579, 2004
PubMed

第IV章 運動療法の実際

P.107 掲載の参考文献
1) Fletcher GF et al : Exercise standards for testing and training : a scientific statement from the American Heart Association. Circulation 128 (8):873-934, 2013
PubMed
2) Pina IL et al : Exercise and heart failure : A statement from the American Heart Association Committee on exercise, rehabilitation, and prevention. Circulation 107 (8):1210-1225, 2003
PubMed
3) Hambrecht R et al : Physical training in patients with stable chronic heart failure:effects on cardiorespiratory fitness and ultrastructural abnormalities of leg muscles. J Am Coll Cardiol 25 (6):1239-1249, 1995
PubMed
4) Belardinelli R et al : Effects of aerobic training in patients with moderate chronic heart failure. G Ital Cardiol 22 (8):919-930, 1992
PubMed
5) Coats AJ et al : Controlled trial of physical training in chronic heart failure : exercise performance, hemodynamics, ventilation, and autonomic function. Circulation 85 (6):2119-2131, 1992
PubMed
6) Hardman AE:Issues of fractionization of exercise (short vs long bouts). Med Sci Sports Exerc 33 (6 Suppl):S421-427, 2001
 
7) Braith RW et al : Resistance exercise : training adaptations and developing a safe exercise prescription. Heart Fail Rev 13 (1):69-79, 2008
PubMed
8) Braith RW et al : Resistance exercise training : its role in the prevention of cardiovascular disease. Circulation 113 (22):2642-2650, 2006
PubMed
9) American College of Sports Medicine : American College of Sports Medicine position stand. Progression models in resistance training for healthy adults. Med Sci Sports Exerc 41 (3):687-708, 2009
PubMed
10) Meyer P et al : High-intensity aerobic interval exercise in chronic heart failure. Curr Heart Fail Rep 10 (2):130-138, 2013
PubMed
11) Weston KS et al : High-intensity interval training in patients with lifestyle-induced cardiometabolic disease:a systematic review and meta-analysis. Br J Sports Med doi:10.1136/bjsports-2013-092576, 2013
 
12) Frey BS : Psychology. Happy people live longer. Science 331 (6017):542-543, 2011
PubMed
13) Lamers SM et al : The impact of emotional well－being on long－term recovery and survival in physical illness:a meta-analysis. J Behav Med 35 (5):538-547, 2012
PubMed
P.134 掲載の参考文献
1) 日本循環器学会 : 心血管疾患におけるリハビリテーションに関するガイドライン (2012年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2012_nohara_h.pdf (2018年6月閲覧)
 
2) Piepoli MF et al : Exercise training in heart failure : from theory to practice. A consensus document of the Heart Failure Association and the European Association for Cardiovascular Prevention and Rehabilitation. Eur J Heart Fail 13 (4):347-357, 2011
 
3) Guralnik JM et al : A short physical performance battery assessing lower extremity function : association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol 49 (2):85-94, 1994
 
4) Matsuzawa Y et al : Association between gait speed as a measure of frailty and risk of cardiovascular events after myocardial infarction. J Am Coll Cardiol 61 (19):1964-1972, 2013
 
5) Watanabe Y et al : Increased muscle size and strength from slow-movement, low-intensity resistance exercise and tonic force generation. J Aging Phys 21 (1):71-84, 2013
PubMed
6) Watanabe Y et al : Effect of very low-intensity resistance training with slow movement on muscle size and strength in healthy older adults. Clin Physiol Funct Imaging 34 (6):463-470, 2014
PubMed
7) Melzer I et al : Association between ankle muscle strength and limit of stability in older adults. Age Ageing 38 (1):119-123, 2009
PubMed
8) 齋藤孝義ほか : 踵上げ反復運動回数と最大1歩幅の比較と転倒との関係. 理療科 31 (6):907-910, 2016
Medical*Online
9) 日本心臓リハビリテーション学会 : 心不全の心臓リハビリテーション標準プログラム (2017年版). http://www.jacr.jp/web/wp-content/uploads/2015/04/shinfuzen2017_2.pdf (2018年6月閲覧)
 

第V章 心肺運動負荷試験・運動機能評価法・運動効果モニタリング

P.173 掲載の参考文献
1) 川久保清ほか : 心疾患患者の学校, 職域, スポーツにおける運動許容条件に関するガイドライン [循環器病の診断と治療に関するガイドライン (2001-2002年度合同研究班)]
 
2) 長嶋正實ほか : 心疾患患者の学校, 職域, スポーツにおける運動許容条件に関するガイドライン (2008年改訂版) [循環器病の診断と治療に関するガイドライン (2007年度合同研究班報告)]
 
3) 野原隆司ほか : 心血管疾患におけるリハビリテーションに関するガイドライン (2012年改訂版) [循環器病の診断と治療に関するガイドライン (2011年度合同研究班報告)]
 
4) 新 スポーツのためのメディカルチェック. 村山正博 (監修), 武者春樹 (編集), 南江堂, 2002
 
5) 公認アスレティックトレーナー専門科目テキスト ワークブック : 健康管理とスポーツ医学. 財団法人日本体育協会指導者育成専門委員会アスレティックトレーナー部会 (監修), 赤間高雄 (編集), 文光堂, 2011
 
6) 谷口興一ほか : 運動負荷テストとその評価法. 南江堂, 1990
 
7) 心肺運動負荷テスト―呼気ガス分析による心肺疾患の新しい見方. 谷口興一 (編集), 南江堂, 1993
 
8) 斎藤宗靖 : 心臓病と運動負荷試験. 中外医学社, 1988
 
9) 伊東春樹ほか : 循環器負荷試験法. 水野康ほか (編集), 診断と治療社, 1991
 
10) Fletcher GF et al : Exercise standards for testing and training : a scientific statement from the American Heart Association. Circulation 128 (8):873-934, 2013
PubMed
11) Wasserman K et al : Exercise physiology in health and disease. Am Rev Respir Dis 112 (2):219-249, 1975
PubMed
12) American Thoracic Society : ATS/ACCP statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 167 (2):211-277, 2003
PubMed
13) Bengtsson J et al : End-tidal to arterial oxygen tension difference as an oxygenation index. Acta Anaesthesiol Scand 45 (3):357-363, 2001
PubMed
P.186 掲載の参考文献
1) Guralnik JM et al : A short physical performance battery assessing lower extremity function : association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol 49 (2):M85-94, 1994
 
2) Working Group on Functional Outcome Measures for Clinical Trials : Functional outcomes for clinical trials in frail older persons : time to be moving. J Gerontol A Biol Sci Med Sci 63 (2):160-164, 2008
 
3) Ostir GV et al : Reliability and sensitivity to change assessed for a summary measure of lower body function:results from the Women's Health and Aging Study. J Clin Epidemiol 55 (9), 916-921, 2002
PubMed
4) Duncan PW et al : Functional reach : a new clinical measure of balance. J Gerontol 45 (6):M192-197, 1990
 
5) Weiner DK et al : Functional reach : a marker of physical frailty. J Am Geriatr Soc 40 (3):203-207, 1992
 
6) Giorgetti MM et al : Reliability of clinical balance outcome measures in the elderly. Physiother Res Int 3 (4):274-283, 1998
PubMed
7) Rockwood K et al : Feasibility and measurement properties of the functional reach and the timed up and go tests in the Canadian study of health and aging. J Gerontol A Biol Sci Med Sci 55 (2):M70-73, 2000
PubMed
8) Duncan PW et al : Functional reach : Predictive validity in a sample of elderly male veterans. J Gerontol 47 (3):M93-98, 1992
 
9) Podsiadlo D et al : The timed "Up & Go" : a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 39 (2):142-148, 1991
 
10) Bischoff HA et al : Self－reported exercise before age 40 : influence on quantitative skeletal ultrasound and fall risk in the elderly. Arch Phys Med Rehabil 82 (6):801-806, 2001
PubMed
11) Samson MM et al : Relationships between physical performance measures, age, height and body weight in healthy adults. Age Ageing 29 (3):235-242, 2000
PubMed
12) Shumway-Cook A et al : Predicting the probability for falls in community-dwelling older adults using the Timed Up & Go Test, Phys Ther 80 (9):896-903, 2000
PubMed
13) Cesari M et al : Prognostic value of usual gait speed in well-functioning older people-results from the Health, Aging and Body Composition Study. J Am Geriatr Soc 53 (10):1675-1680, 2005
PubMed
14) Quach L et al : The nonlinear relationship between gait speed and falls : the Maintenance of Balance, Independent Living, Intellect, and Zest in the Elderly of Boston Study. J Am Geriatr Soc 59 (6):1069-1073, 2011
PubMed
15) Cruz-Jentoft AJ et al : Sarcopenia : European consensus on definition and diagnosis : Report of the European Working Group on Sarcopenia in Older People. Age Ageing 39 (4):412-423, 2010
 
16) Chen LK et al : Sarcopenia in Asia : consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 15 (2):95-101, 2014
 
17) Mahoney FI et al : Functional evaluation : The Barthel Index. Md State Med J 14:61-65, 1965
PubMed
18) Hamilton BB et al : A uniform national data system for medical rehabilitation. In : Fuhrer MJ : Rehabilitation outcomes : analysis and measurement. Baltimore, pp137-147, 1987
 
19) 千野直一ほか : 脳卒中患者の機能評価-SIASとFIMの実際. シュプリンガー・フェアラーク東京, 1997
 
20) Katz S et al : Studies of illness in the aged. The index of ADL : a standardized measure of biological and psychosocial function. J Am Med Assoc 185 (12):914-919, 1963
 
21) Lee DH et al : Frail patients are at increased risk for mortality and prolonged institutional care after cardiac surgery. Circulation 121 (8):973-978, 2010
PubMed
22) Craig CL et al : lnternational physical activity questionnaire : 12-country reliability and validity, Med Sci Sports Exerc 35 (8):1381-1395, 2003
 
23) Clemes SA et al : How many days of pedometer monitoring predict monthly ambulatory activity in adults? Med Sci Sports Exerc 40 (9):1589-1595, 2008
PubMed
24) 村瀬訓生ほか : 身体活動量の国際標準化-IPAQ日本語版の信頼性, 妥当性の評価-. 厚生の指標 49 (11):1-9, 2002
 
25) Tomata Y et al : [Validation of the Kihon Checklist for predicting the risk of 1-year incident long-term care insurance certification : the Ohsaki Cohort 2006 Study]. Nihon Koshu Eisei Zasshi 58 (1):3-13, 2011
PubMed
26) Lubben JE : Assessing social networks among elderly populations. Family & Community Health 11 (3):42-52, 1988
 
27) Lubben JE et al : Centrality of social ties to the health and well-being of older adults, In:Social work and health care in an aging world, Berkman L et al (eds), Springer Press, pp319-350, 2003
 
28) Heitzmann CA et al : Assessment of methods for measuring social support. Health Psychol 7 (1):75-109, 1988
PubMed
29) 栗本鮎美ほか : 日本語版Lubben Social Network Scale 短縮版 (LSNS-6) の作成と信頼性および妥当性の検討. 日老医誌 48 (2):149-157, 2011
 
30) Jaarsma T et al : Development and testing of the European Heart Failure Self-Care Behaviour Scale. Eur J Heart Fail 5 (3):363-370, 2003
PubMed
31) Kato N et al : Validity and Reliability of the Japanese Version of the European Heart Failure Self-Care Behavior Scale. Eur J Cardiovasc Nurs 7 (4):284-289, 2008
PubMed
P.193 掲載の参考文献
1) Ades PA : Cardiac rehabilitation and secondary prevention of coronary heart disease. N Engl J Med 345 (12):892-902, 2001
PubMed
2) Leon AS et al : Cardiac rehabilitation and secondary prevention of coronary heart disease : an American Heart Association scientific statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity), in collaboration with the American association of Cardiovascular and Pulmonary Rehabilitation. Circulation 111 (13):369-376, 2005
 
3) Pina IL et al : Exercise and heart failure : A statement from the American Heart Association Committee on exercise, rehabilitation, and prevention. Circulation 107 (8):1210-1225, 2003
PubMed
4) Lavie CJ et al : Effects of cardiac rehabilitation and exercise training in obese patients with coronary artery disease. Chest 109 (1):52-56, 1996
PubMed
5) Brochu M et al : Modest effects of exercise training alone on coronary risk factors and body composition in coronary patients. J Cardiopulm Rehabil 20 (3):180-188, 2000
PubMed
6) Anker SD et al : Cardiac cachexia : a syndrome with impaired survival and immune and neuroendocrine activation. Chest 115 (3):836-847, 1999
PubMed
7) Bouchard C (ed) : Physical activity and obesity. Human Kinetics, 2000
 
8) Pescatello LS et al : American College of Sports Medicine position stand. Exercise and hypertension. Med Sci Sports Exerc 36 (3):533-553, 2004
PubMed
9) Hagberg JM : Exercise, fitness, and hypertension. In exercise, fitness, and health : a consensus of current knowledge, C. Bouchard et al (eds), Champaign, Human Kinetics, pp 455-466, 1990
 
10) Laughlin MH : Joseph B. Wolfe Memorial lecture. Physical activity in prevention and treatment of coronary disease : the battle line is in exercise vascular cell biology. Med Sci Sports Exerc 36 (3):352-362, 2004
 
11) Dishman RK et al : Physical Activity Epidemiology. 4rd ed, Human Kinetics, 2004
 
12) Kelley GA et al : Progressive resistance exercise and resting blood pressure:A meta-analysis of randomized controlled trials. Hypertension 35 (3):838-843, 2000
PubMed
13) Mendoza SG et al : Effect of physical training on lipids, lipoproteins, apolipoproteins, lipases, and endogenous sex hormones in men with premature myocardial infarction. Metabolism 40:368-377, 1991
PubMed
14) Warner JG Jr et al : Long-term (5-year) changes in HDL cholesterol in cardiac rehabilitation patients. Do sex differences exist? Circulation 92 (4):773-777, 1995
PubMed
15) Kraus WE et al : Effects of the amount and intensity of exercise on plasma lipoproteins. N Engl J Med 347 (19):1483-1492, 2002
 
16) Vasankari TJ et al : Reduced oxidized LDL levels after a 10-month exercise program. Med Sci Sports Exerc 30 (10):1496-1501, 1998
PubMed
17) Wang JS et al : Effects of exercise training and detraining on oxidized low-density lipoproteinpotentiated platelet function in men. Arch Phys Med Rehabil 85 (9):1531-1537, 2004
PubMed
18) Dylewicz P et al : Beneficial effect of short-term endurance training on glucose metabolism during rehabilitation after coronary bypass surgery. Chest 117 (1):47-51, 2000
PubMed
19) Kelley DE et al : Effects of exercise on glucose homeostasis in type 2 diabetes mellitus. Med Sci Sports Exerc 33 (6 supple) : S495-501, S528-529, 2001
 
20) Stewart KJ : Exercise training and the cardiovascular consequences of type 2 diabetes and hypertension : plausible mechanisms for improving cardiovascular health. JAMA 288 (13):1622-1631, 2002
PubMed
21) Durak EP et al : Randomized crossover study of effect of resistance training on glycemic control, muscular strength, and cholesterol in type I diabetic men. Diabetes Care 13 (10):1039-1043, 1990
PubMed
22) Ross R : Atherosclerosis-an inflammatory disease. N Engl J Med 340 (2):115-126, 1999
PubMed
23) Selvin E et al : The effect of weight loss on C-reactive protein : a systematic review. Arch Intern Med 167 (1):31-39, 2007
 
24) Okita K et al : Can exercise training with weight loss lower serum C-reactive protein levels? Arterioscler Thromb Vasc Biol 24 (10):1868-1873, 2004
 
25) Goldhammer E et al : Exercise training modulates cytokines activity in coronary heart disease patients. Int J Cardiol 100 (1):93-99, 2005
PubMed
26) 沖田孝一:運動と酸化ストレス. 医学のあゆみ 218 (1):105-110, 2006
Medical*Online
27) Rauramaa R et al : Dose-response and coagulation and hemostatic factors. Med Sci Sports Exerc 33 (6 Suppl):S516-520 ; discussion S528-529, 2001
 
28) Lindahl B et al : Improved fibrinolysis by intense lifestyle intervention. A randomized trial in subjects with impaired glucose tolerance. J Intern Med 246 (1):105-112, 1999
PubMed
29) Eisenberg S et al : Changes in blood viscosity, hematocrit value, and fibrinogen concentration in subjects with congestive heart failure. Circulation 30 (5):686-693, 1964
 
30) Lowe GD et al : Blood viscosity and risk of cardiovascular event : the Edinburgh artery study. Br J Haematol 96 (1):168-173, 1997
PubMed
31) Szmitko PE et al : New markers of inflammation and endothelial cell activation : Part I. Circulation 108 (16):1917-1923, 2003
 
32) Roberts CK et al : Effect of a short-term diet and exercise intervention on oxidative stress, inflammation, MMP-9, and monocyte chemotactic activity in men with metabolic syndrome factors. J Appl Physiol 100 (5):1657-1665, 2006
 
33) Miller WL et al : Serial biomarker measurements in ambulatory patients with chronic heart failure : the importance of change over time. Circulation 116 (3):249-257, 2007
PubMed
34) Passino C et al : Aerobic training decreases B-type natriuretic peptide expression and adrenergic activation in patients with heart failure. J Am Coll Cardiol 47 (9):1835-1839, 2006
PubMed
35) Mehra MR et al : Obesity and suppressed B-type natriuretic peptide levels in heart failure. J Am Coll Cardiol 43 (9):1590-1595, 2004
PubMed
36) Kojda G et al : Molecular mechanisms of vascular adaptations to exercise. Physical activity as an effective antioxidant therapy? Cardiovasc Res 67 (2):187-197, 2005
PubMed
37) Tousoulis D et al : Inflammation and endothelial dysfunction as therapeutic targets in patients with heart failure. Int J Cardiol 100 (3):347-353, 2005
PubMed
38) Katz SD et al : Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure. Circulation 111 (3):310-314, 2005
PubMed
39) Hambrecht R et al : Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure. Circulation 98 (24):2709-2715, 1998
PubMed
40) Tulppo MP et al : Physiological background of the loss of fractal heart rate dynamics. Circulation 112 (3):314-319, 2005
PubMed
41) Tsuji H et al : Reduced heart rate variability and mortality risk in an elderly cohort. The Framingham Heart Study. Circulation 90 (2):878-883, 1994
 
42) Nolan J et al : Prospective study of heart rate variability and mortality in chronic heart failure:results of the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-Heart). Circulation 98 (15):1510-1516, 1998
PubMed
43) Levy WC et al : Effect of endurance exercise training on heart rate variability at rest in healthy young and older men. Am J Cardiol 82 (10):1236-1241, 1998
 
44) Leitch JW et al : Randomized trial of a hospital-based exercise training program after acute myocardial infarction : cardiac autonomic effects. J Am Coll Cardiol 29 (6):1263-1268, 1997
PubMed
45) Iellamo F et al : Effects of residential exercise training on baroreflex sensitivity and heart rate variability in patients with coronary artery disease : a randomized, controlled study. Circulation 102 (21):2588-2592, 2000
PubMed
46) Furlan R et al : Modifications of cardiac autonomic profile associated with a shift schedule of work. Circulation 102 (16):1912-1916, 2000
PubMed

第VI章 栄養管理・食事療法 - カヘキシーへの対策と課題 -

P.198 掲載の参考文献
1) Anker SD et al : Wasting as independent risk factor for mortality in chronic heart failure. Lancet 349 (9058):1050-1053, 1997
PubMed
2) Evans WJ et al : Cachexia : a new definition. Clin Nutr 27 (6):793-799, 2008
PubMed
3) Collamati A et al : Sarcopenia in heart failure : mechanisms and therapeutic strategies. J Geriatr Cardiol 13 (7):615-624, 2016
PubMed
4) Saitoh M et al : Muscle wasting in heart failure : The role of nutrition. Wien Klin Wochenschr 128 (Suppl 7):455-465, 2016
 
P.200 掲載の参考文献
1) Elia M : Screening for malnutrition : A multidisciplinary responsibility. Development and Use of the Malnutrition Universal Screening Tool ('MUST') for Adults. Redditch : BAPEN ; 2003
 
2) Kondrup J et al : Nutritional Risk Screening (NRS 2002) : a new method based on an analysis of controlled clinical trials. Clin Nutr 22 (3):321-336, 2003
 
3) Rubenstein LZ et al : Screening for undernutrition in geriatric practice : developing the short-form mininutritional assessment (MNA-SF). J Gerontol A Biol Sci Med Sci 56 (6):M366-372, 2001
 
4) Detsky AS et al : What is subjective global assessment of nutritional status? JPEN J Parenter Enteral Nutr 11 (1):8-13, 1987
PubMed
5) Ignacio de Ulibarri J et al : CONUT : a tool for controlling nutritional status. First validation in a hospital population. Nutr Hosp 20 (1):38-45, 2005
 
6) Bouillanne O et al : Geriatric Nutritional Risk Index : a new index for evaluating at-risk elderly medical patients. Am J Clin Nutr 82 (4):777-783, 2005
PubMed
P.202 掲載の参考文献
1) Adigun AQ et al : The effects of enalapril-digoxin-diuretic combination therapy on nutritional and anthropometric indices in chronic congestive heart failure:preliminary findings in cardiac cachexia. Eur J Heart Fail 3 (3):359-363, 2001
PubMed
2) Yusuf S et al : Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 325 (5):293-302, 1991
PubMed
3) Anker SD et al : Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors : an observational study. Lancet 361 (9363):1077-1083, 2003
PubMed
4) Stewart Coats AJ et al : Espindolol for the treatment and prevention of cachexia in patients with stage III/IV non-small cell lung cancer or colorectal cancer:a randomized, double-blind, placebo-controlled, international multicentre phase II study (the ACT-ONE trial). J Cachexia Sarcopenia Muscle 7 (3):355-365, 2016
PubMed
5) Ebner N et al : Mechanism and novel therapeutic approaches to wasting in chronic disease. Maturitas. 75 (3):199-206, 2013
PubMed
6) Bibas L et al : Therapeutic interventions for frail elderly patients : part I. Published randomized trials. Prog Cardiovasc Dis 57 (2):134-143, 2014
PubMed
7) Bendayan M et al : Therapeutic interventions for frail elderly patients : part II. Ongoing and unpublished randomized trials. Prog Cardiovasc Dis 57 (2):144-151, 2014
PubMed
P.204 掲載の参考文献
1) Kenchaiah S et al : Obesity and the risk of heart failure. N Engl J Med 347 (5):305-313, 2002
PubMed
2) Anker SD et al : Wasting as independent risk factor for mortality in chronic heart failure. Lancet 349 (9058):1050-1053, 1997
PubMed
3) Kenchaiah S et al : Body mass index and prognosis in patients with chronic heart failure : insights from the Candesartan in Heart failure : Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation 116 (6):627-636, 2007
PubMed
4) Hamaguchi S et al : Body mass index is an independent predictor of long-term outcomes in patients hospitalized with heart failure in Japan. Circ J 74 (12):2605-2611, 2010
PubMed
5) Komukai K et al : Impact of body mass index on clinical outcome in patients hospitalized with congestive heart failure. Circ J 76 (1):145-151, 2012
PubMed
P.213 掲載の参考文献
1) Shai I et al : Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med 359 (3):229-241, 2008
 
2) 糖尿病食事療法のための食品交換表 第6版, 日本糖尿病学会 (編著), 文光堂, 2002
 
3) Davis C et al : Definition of the Mediterranean Diet ; a Literature Review. Nutrients 7 (11):9139-9153, 2015
PubMed
4) D'Alessandro A et al : Mediterranean diet pyramid : a proposal for Italian people. Nutrients 6 (10):4302-4316, 2014
PubMed
5) de Lorgeril M et al : Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction : final report of the Lyon Diet Heart Study. Circulation 99 (6):779-785, 1999
PubMed
6) Paoli A et al : Beyond weight loss : a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets. Eur J Clin Nutr 67 (8):789-796, 2013
PubMed
7) Campmans-Kuijpers MJ et al : The association of substituting carbohydrates with total fat and different types of fatty acids with mortality and weight change among diabetes patients. Clin Nutr 35 (5):1096-1102, 2016
PubMed
8) Skeaff CM et al : Dietary fat and coronary heart disease : summary of evidence from prospective cohort and randomised controlled trials. Ann Nutr Metab 55 (1-3):173-201, 2009
 
9) Pietinen P et al : Intake of fatty acids and risk of coronary heart disease in a cohort of Finnish men. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am J Epidemiol 145 (10):876-887, 1997
 
10) Brouwer IA : Omega-3 PUFA : good or bad for prostate cancer? Prostaglandins Leukot Essent Fatty Acids 79 (3-5):97-99, 2008
 
11) Lovegrove C et al : Systematic review of prostate cancer risk and association with consumption of fish and fish-oils : analysis of 495,321 participants. Int J Clin Pract 69 (1):87-105, 2015
PubMed
12) Bao Y et al : Association of nut consumption with total and cause-specific mortality. N Engl J Med 369 (21):2001-2011, 2013
PubMed
13) Oomen CM et al : Association between trans fatty acid intake and 10-year risk of coronary heart disease in the Zutphen Elderly Study : a prospective population-based study. Lancet 357 (9258):746-751, 2001
PubMed
14) 日本動脈硬化学会 : ACC/AHA「心血管疾患リスク低減のための生活習慣マネジメントのガイドライン」に対する日本動脈硬化学会の見解. http://www.j-athero.org/outline/guideline_lifestyle.html (2018年6月閲覧)
 

トピックス

P.220 掲載の参考文献
1) Li S et al : Exercise Mimetics : Running Without a Road Map. Clin Pharmacol Ther 101 (2):188-190, 2017
PubMed
2) Fan W et al : Exercise Mimetics : Impact on Health and Performance. Cell Metab 25:242-247, 2017
PubMed
3) Noto H et al : Latest insights into the risk of cancer in diabetes. J Diabetes Investig 4 (3):225-232, 2013
PubMed
4) Blagosklonny MV : From rapalogs to anti-aging formula. Oncotarget 8 (22):35492-35507, 2017
PubMed
5) Handschin C : Caloric restriction and exercise "mimetics" : Ready for prime time? Pharmacol Res 103:158-166, 2016
PubMed
6) Lopez-Lluch G et al : Calorie restriction as an intervention in ageing. J Physiol 594 (8):2043-2060, 2016
PubMed
P.226 掲載の参考文献
1) Ristow M : Unraveling the truth about antioxidants : mitohormesis explains ROS-induced health benefits. Nat Med 20 (7):709-711, 2014
PubMed
2) Mankowski RT et al : Dietary Antioxidants as Modifiers of Physiologic Adaptations to Exercise. Med Sci Sports Exerc 47 (9):1857-1868, 2015
PubMed
3) Webb R et al : The ability of exercise-associated oxidative stress to trigger redox-sensitive signalling responses. Antioxidants (Basel) 6 (3). pii:E63, 2017
 
4) Reuland DJ et al : The role of Nrf 2 in the attenuation of cardiovascular disease. Exerc Sport Sci Rev 41 (3):162-168, 2013
 
5) Bjelakovic G et al : Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev 14 (3), CD007176, 2012
PubMed
6) Bjelakovic G et al : Mortality in randomized trials of antioxidant supplements for primary and secondary prevention : systematic review and meta-analysis. JAMA 297 (8):842-857, 2007
PubMed
7) Fortmann SP et al : Vitamin and mineral supplements in the primary prevention of cardiovascular disease and cancer : An updated systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med 159 (12):824-834, 2013
 
8) Mikus CR et al : Simvastatin impairs exercise training adaptations. J Am Coll Cardiol 62 (8):709-714, 2013
PubMed
9) Schirris TJ et al : Statin-Induced Myopathy Is Associated with Mitochondrial Complex III Inhibition. Cell Metab 22 (3):399-407, 2015
PubMed
10) Deichmann RE et al : The Interaction Between Statins and Exercise : Mechanisms and Strategies to Counter the Musculoskeletal Side Effects of This Combination Therapy. Ochsner J 15 (4):429-437, 2015
PubMed
11) Noto H et al : Latest insights into the risk of cancer in diabetes. J Diabetes Investig 4 (3):225-232, 2013
PubMed
12) Malin SK et al : Impact of Metformin on Exercise-Induced Metabolic Adaptations to Lower Type 2 Diabetes Risk. Exerc Sport Sci Rev 44 (1):4-11, 2016
PubMed
13) Xu X et al : Exercise training combined with angiotensin II receptor blockade reduces oxidative stress after myocardial infarction in rats. Exp Physiol 95 (10):1008-1015, 2010
PubMed
P.233 掲載の参考文献
1) Lee NK et al : Endocrine regulation of energy metabolism by the skeleton. Cell 130 (3):456-469, 2007
PubMed
2) Fukumoto S et al : Bone as an endocrine organ. Trends Endocrinol Metab 20 (5):230-236, 2009
PubMed
3) Ferron M et al : Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell 142 (2):296-308, 2010
PubMed
4) Zoch ML et al : New insights into the biology of osteocalcin. Bone 82:42-49, 2016
PubMed
5) Shane E et al : Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure. Am J Med 103 (3):197-207, 1997
PubMed
6) Kenny AM et al : Femoral bone mineral density in patients with heart failure. Osteoporos Int 17 (9):1420-1427, 2006
PubMed
7) Anker SD et al : Loss of bone mineral in patients with cachexia due to chronic heart failure. Am J Cardiol 83 (4):612-615, 1999
PubMed
8) Schleithoff SS et al : Low serum levels of intact osteocalcin in patients with congestive heart failure. J Bone Miner Metab 21 (4):247-252, 2003
PubMed
9) Gonciulea A et al : The dynamic skeleton. Rev Endocr Metab Disord 16 (2):79-91, 2015
PubMed
10) Da J et al : Serum Phosphorus and Progression of CKD and Mortality : A Meta-analysis of Cohort Studies. Am J Kidney Dis 66 (2):258-265, 2015
PubMed
11) Tonelli M et al : Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 112 (17):2627-2633, 2005
PubMed
12) Bai W et al : Serum phosphorus, cardiovascular and all-cause mortality in the general population : A metaanalysis. Clin Chim Acta 461:76-82, 2016
PubMed
13) Kuro-o M : A potential link between phosphate and aging--lessons from Klotho-deficient mice. Mech Ageing Dev 131 (4):270-275, 2010
PubMed
14) Ellam TJ et al : Phosphate : the new cholesterol? The role of the phosphate axis in non-uremic vascular disease. Atherosclerosis 220 (2):310-318, 2012
PubMed
15) Scialla JJ et al : Fibroblast growth factor-23 and cardiovascular events in CKD. J Am Soc Nephrol 25 (2):349-360, 2014
PubMed

書評

最近チェックした商品履歴

Loading...